Treatment of Urinary Tract Infection (UTI)

Classification (Determines Treatment Approach)

UTIs are classified into:

Uncomplicated - occurs in healthy women with normal genitourinary tracts
Complicated - associated with structural/functional abnormalities, catheters, pregnancy, immunosuppression, male sex, diabetes, or renal disease (see host factors table below)
Recurrent - >2 UTIs in 6 months or >3 UTIs in 12 months
Asymptomatic bacteriuria - colonization without symptoms; only treat in specific circumstances (pregnancy, pre-urologic procedures)

Host factors for complicated UTI:

Obstruction (strictures, tumor, BPH, stones)
Functional (neurogenic bladder, vesicoureteral reflux, pregnancy)
Urologic interventions (catheters, stents, cystoscopy)
Metabolic/congenital disease
Immunologic abnormalities (transplant)

Common Pathogens

E. coli is responsible for 75-90% of uncomplicated UTIs. Other pathogens include Staphylococcus saprophyticus, Klebsiella, Proteus, Enterococcus, and Pseudomonas (in complicated/nosocomial cases).

1. Uncomplicated Cystitis (Adult Women)

No initial urine culture is required for straightforward uncomplicated cystitis. Consider local resistance patterns - if resistance is ≥20%, use an alternative agent.

Drug	Regimen	Notes
Nitrofurantoin monohydrate/macrocrystals	100 mg twice daily × 5 days	First-line; not effective in pyelonephritis
TMP-SMX DS (160/800 mg)	1 tab twice daily × 3 days	Avoid if local resistance >20%
Fosfomycin	3 g single dose	Convenient; lower efficacy than others for early pyelonephritis
Pivmecillinam	400 mg twice daily × 5 days	Where available; lower efficacy than some agents

Fluoroquinolones should be reserved for important uses other than uncomplicated cystitis, due to resistance and adverse effect concerns.

Beta-lactams (amoxicillin-clavulanate, cefpodoxime, cefdinir, cefaclor in 3-7 day regimens) are appropriate when first-line agents cannot be used.

2. Outpatient Pyelonephritis / Complicated UTI

Urine culture is advised. Treat for at least 7 days (mild) to 14 days (severe/clear pyelonephritis). Admit if significantly ill, unable to retain fluids or medications, or pregnant. Consider an IV dose of ceftriaxone if sensitivities are uncertain.

Drug	Regimen
Ciprofloxacin	500 mg twice daily × 5-7 days
Levofloxacin	750 mg once daily × 5-7 days
TMP-SMX DS	1 tab twice daily × 14 days (only if susceptibility known)
Amoxicillin-clavulanate	875/125 mg twice daily
Cefpodoxime	400 mg twice daily × 7-14 days

3. Inpatient Management - Pyelonephritis / Complicated UTI

Empiric IV options (from Tintinalli's Emergency Medicine):

Drug	Dose
Ciprofloxacin	400 mg IV every 12 h
Ceftriaxone	1-2 g IV once daily
Cefotaxime	1-2 g IV every 8 h
Gentamicin or tobramycin	3 mg/kg/day ± ampicillin 2 g q6h
Piperacillin-tazobactam	3.375 g IV every 6 h
Cefepime	1-2 g IV every 8 h
Ertapenem	1 g IV daily
Meropenem/Imipenem	1 g q8h / 500 mg q8h (for MDR)

After clinical improvement with IV antibiotics, step down to oral agents based on culture sensitivities. Total duration: 7-14 days for most; 21 days for urosepsis.

4. Special Situations

UTI in Men

Any UTI in a young man should be assumed complicated until proven otherwise. Treat 7-14 days; fluoroquinolones are preferred due to prostate penetration. Men without immunocompromise may do well with 7 days rather than 14.

Pregnancy

Safe agents: nitrofurantoin (avoid near term - risk of neonatal hemolysis), beta-lactams (amoxicillin, cephalosporins), fosfomycin
Avoid: fluoroquinolones, tetracyclines, TMP-SMX in first trimester and near term
Treat asymptomatic bacteriuria in pregnancy (unlike non-pregnant patients)
Screen at first prenatal visit

Catheter-Associated UTI (CAUTI)

Replace or remove the catheter before collecting cultures and initiating antibiotics
Treat symptomatic CAUTI for 7-14 days
Do not treat asymptomatic bacteriuria in catheterized patients

Recurrent UTI

Culture all patients; treat empirically with uncomplicated cystitis regimens
Relapses (same organism within 30 days): use an alternative agent from complicated UTI regimens
Prophylaxis options: continuous low-dose antibiotics, postcoital antibiotics, or patient-initiated self-treatment

Urosepsis

Broad-spectrum IV antibiotics immediately; follow sepsis bundle
Early imaging (CT with contrast) to identify source and obstruction
Blood cultures before starting antibiotics
Total treatment: up to 21 days

5. Asymptomatic Bacteriuria

Do NOT treat in most patients (including elderly, diabetics, catheterized patients) - treatment increases adverse effects and resistance without benefit.

Treat only in:

Pregnant women
Patients undergoing urologic procedures with mucosal disruption

Recent Evidence Updates

Key recent publications worth noting:

WikiGuidelines 2024 Consensus (PMID 39495518) - comprehensive guidelines for UTI prevention, diagnosis, and management across pediatric and adult populations (JAMA Network Open, 2024)
Short vs. Long antibiotic courses for pyelonephritis (PMID 40228579) - 2025 living meta-analysis supporting shorter antibiotic durations for pyelonephritis and complicated UTI; watch for updates to duration recommendations
Catheter replacement in CAUTI (PMID 38916643) - systematic review on catheter replacement practices

Sources: Tintinalli's Emergency Medicine (9e), pp. 620-625 | Goldman-Cecil Medicine (International ed.), Chapter 263 | Harriet Lane Handbook (23e)

This is a shared conversation. Sign in to Orris to start your own chat.